fda stance on compounded semaglutide is not the same as FDA-approved. The has documented dosing errors and hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before Compounded Semaglutide Manufacturing Ban

The 60-day guarantee provides a risk-reduced evaluation window - though the timing relative to the 2-package supply is tight

However, the broad distribution of GLP-1 receptors across various tissues, such as the pancreas, lungs, kidneys, central nervous system, cardiovascular system, gastrointestinal tract, skin, and thyroid gland, has raised concerns about the potential impact of GLP-1 RAs on cancer development and progression [23]

With proper guidance, GLP-1 medications can be safely used across all CKD stages, including dialysis, offering a tailored solution for diabetes and kidney health management

I had never used -- treatment before, so before purchasing , I did a lot of research and read through several case studies